Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News WIRB-Copernicus acquires clinical trial consultant Waife & Associates WIRB-Copernicus Group (WCG), a clinical services organization, said that its clinical services division has acquired Waife & Associates… bypharmanewsdailyNovember 9, 2019